# RBC Life Sciences, Inc. (RBCL)

> Consumer Defensive · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RBCL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2017 | $ 22.02M | $ -565.2K | $ -676.2K | $ 0 | $ 6.58M |
| 2016 | $ 35.46M | $ -1.04M | $ 9.2K | $ 0 | $ 7.13M |
| 2015 | $ 34.21M | $ -1.04M | $ -6.22M | $ 0 | $ 7.88M |
| 2014 | $ 39.95M | $ -851.8K | $ -2.38M | $ 1.14M | $ 8.43M |
| 2013 | $ 36.23M | $ -711.1K | $ 38.7K | $ 1.35M | $ 9.01M |
| 2012 | $ 36.33M | $ -101.8K | $ -519.8K | $ 1.55M | $ 9.52M |
| 2011 | $ 41.79M | $ -105.0K | $ -330.7K | $ 1.73M | $ 9.86M |
| 2010 | $ 42.63M | $ 844.5K | $ 577.6K | $ 1.90M | $ 9.88M |
| 2009 | $ 37.74M | $ -507.0K | $ -1.48M | $ 2.05M | $ 9.22M |
| 2008 | $ 46.04M | $ 2.45M | $ -2.22M | $ 2.20M | $ 9.39M |
| 2007 | $ 40.93M | $ 2.56M | $ 5.60M | $ 2.33M | $ 7.58M |
| 2006 | $ 32.85M | $ 660.5K | $ 2.41M | $ 3.02M | $ 5.48M |
| 2005 | $ 29.32M | $ 896.4K | $ 1.06M | $ 3.23M | $ 4.90M |
| 2004 | $ 26.71M | $ 813.4K | $ 1.30M | $ 3.28M | $ 4.32M |
| 2003 | $ 28.13M | $ -500.7K | $ 393.0K | $ 3.59M | $ 3.74M |
| 2002 | $ 39.80M | $ -611.1K | $ 1.44M | $ 4.59M | $ 3.19M |
| 2001 | $ 52.14M | $ -1.80M | $ -4.83M | $ 5.46M | $ 3.59M |
| 2000 | $ 60.56M | $ 772.7K | $ 240.0K | $ 1.72M | $ 4.80M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.80 |
| Current Ratio | 1.70 |

## Other views

- [Metrics](https://sponda.capital/en/RBCL.md)
- [Charts](https://sponda.capital/en/RBCL/charts.md)
- [Compare](https://sponda.capital/en/RBCL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.